The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DETERRED: PD-L1 blockade to evaluate the safety of lung cancer therapy using carboplatin, paclitaxel, and radiation combined with MPDL3280A (atezolizumab).
 
Steven H. Lin
Honoraria - AstraZeneca/MedImmune; ProCure; US Oncology
Research Funding - Genentech/Roche; Hitachi Chemical; Peregrine Pharmaceuticals; STCube Pharmaceuticals Inc.
Travel, Accommodations, Expenses - STCube Pharmaceuticals Inc.; US Oncology
 
Yan Lin
No Relationships to Disclose
 
Justina Price
No Relationships to Disclose
 
Matthew Parker
No Relationships to Disclose
 
Daniel Richard Gomez
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Merck
 
James William Welsh
Leadership - Healios; MolecularMatch; Oncorena
Stock and Other Ownership Interests - Checkmate Pharmaceuticals; Healios; Mavu Pharmaceutical ; MolecularMatch; Oncorena; Reflexion Medical
Consulting or Advisory Role - Checkmate Pharmaceuticals; Mavu Pharmaceutical ; MolecularMatch; Reflexion Medical; Varian Medical Systems
Research Funding - Bristol-Myers Squibb; Calithera Biosciences; GlaxoSmithKline; Incyte; Merck; Varian Medical Systems
 
Ritsuko Komaki
No Relationships to Disclose
 
Jonathan M. Kurie
No Relationships to Disclose
 
George R. Simon
No Relationships to Disclose
 
George R. Blumenschein
Honoraria - Abbvie/Genentech; Bayer; Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck
Research Funding - Abbvie; AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; GlaxoSmithKline; Merck; Novartis; Xcovery
 
Jenean A. Young
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
See-Chun Phan
Employment - Genentech/Roche
Leadership - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Alan Sandler
Employment - Genentech/Roche
Leadership - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Vassiliki Papadimitrakopoulou
Consulting or Advisory Role - ARIAD; AstraZeneca; Biothera; Clovis Oncology; Genentech; Genentech; Gensignia Life Sciences; Janssen; Lilly; Merck
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Anne S. Tsao
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Genentech/Roche; Imedex; Lilly; MedImmune; Novartis
Research Funding - Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Seagen
Travel, Accommodations, Expenses - Novartis